Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,649 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Higher rates of cefiderocol resistance among NDM producing Klebsiella bloodstream isolates applying EUCAST over CLSI breakpoints.
Isler B, Vatansever C, Özer B, Çınar G, Aslan AT, Falconer C, Bauer MJ, Forde B, Şimşek F, Tülek N, Demirkaya H, Menekşe Ş, Akalin H, Balkan İİ, Aydın M, Tigen ET, Demir SK, Kapmaz M, Keske Ş, Doğan Ö, Arabacı Ç, Yağcı S, Hazırolan G, Bakır VO, Gönen M, Saltoğlu N, Azap A, Azap Ö, Akova M, Ergönül Ö, Can F, Paterson DL, Harris PNA. Isler B, et al. Among authors: aydin m. Infect Dis (Lond). 2023 Sep;55(9):607-613. doi: 10.1080/23744235.2023.2226709. Epub 2023 Jun 30. Infect Dis (Lond). 2023. PMID: 37391868 Free article.
Healthcare-associated Gram-negative bloodstream infections: antibiotic resistance and predictors of mortality.
Ergönül Ö, Aydin M, Azap A, Başaran S, Tekin S, Kaya Ş, Gülsün S, Yörük G, Kurşun E, Yeşilkaya A, Şimşek F, Yılmaz E, Bilgin H, Hatipoğlu Ç, Cabadak H, Tezer Y, Togan T, Karaoğlan I, İnan A, Engin A, Alışkan HE, Yavuz SŞ, Erdinç Ş, Mulazimoglu L, Azap Ö, Can F, Akalın H, Timurkaynak F; Turkish Society of Clinical Microbiology and Infectious Diseases, Healthcare-Related Infections Study Group. Ergönül Ö, et al. Among authors: aydin m. J Hosp Infect. 2016 Dec;94(4):381-385. doi: 10.1016/j.jhin.2016.08.012. Epub 2016 Aug 21. J Hosp Infect. 2016. PMID: 27717604
Rapid emergence of colistin resistance and its impact on fatality among healthcare-associated infections.
Aydın M, Ergönül Ö, Azap A, Bilgin H, Aydın G, Çavuş SA, Demiroğlu YZ, Alışkan HE, Memikoğlu O, Menekşe Ş, Kaya Ş, Demir NA, Karaoğlan I, Başaran S, Hatipoğlu Ç, Erdinç Ş, Yılmaz E, Tümtürk A, Tezer Y, Demirkaya H, Çakar ŞE, Keske Ş, Tekin S, Yardımcı C, Karakoç Ç, Ergen P, Azap Ö, Mülazımoğlu L, Ural O, Can F, Akalın H; Turkish Society of Clinical Microbiology and Infectious Diseases, Healthcare-related Infections Study Group, Turkey. Aydın M, et al. Among authors: aydin g. J Hosp Infect. 2018 Mar;98(3):260-263. doi: 10.1016/j.jhin.2017.11.014. Epub 2017 Dec 15. J Hosp Infect. 2018. PMID: 29248504
Effect of initial antifungal therapy on mortality among patients with bloodstream infections with different Candida species and resistance to antifungal agents: A multicentre observational study by the Turkish Fungal Infections Study Group.
Doğan Ö, Yeşilkaya A, Menekşe Ş, Güler Ö, Karakoç Ç, Çınar G, Kapmaz M, Aydın M, Keske Ş, Şahin S, Hacıseyitoğlu D, Yalçın D, Tekin S, Ataç N, Albayrak Ö, Aksu ED, Can F, Ergönül Ö. Doğan Ö, et al. Among authors: aydin m. Int J Antimicrob Agents. 2020 Jul;56(1):105992. doi: 10.1016/j.ijantimicag.2020.105992. Epub 2020 Apr 24. Int J Antimicrob Agents. 2020. PMID: 32335275
Changes in antimicrobial resistance and outcomes of health care-associated infections.
Aydın M, Azak E, Bilgin H, Menekse S, Asan A, Mert HTE, Yulugkural Z, Altunal LN, Hatipoğlu ÇA, Tuncer Ertem G, Altunok ES, Demirkaya MH, Çeviker SA, Akgul F, Memis Z, Konya P, Azap A, Aydin G, Korkmaz D, Karakoç ZÇ, Yapar D, Karakecili F, Gunal O, Keske S, Kapmaz M, Kader C, Demirel A, Ergönül Ö. Aydın M, et al. Among authors: aydin g. Eur J Clin Microbiol Infect Dis. 2021 Aug;40(8):1737-1742. doi: 10.1007/s10096-020-04140-y. Epub 2021 Feb 14. Eur J Clin Microbiol Infect Dis. 2021. PMID: 33586014
Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey.
Tanriover MD, Doğanay HL, Akova M, Güner HR, Azap A, Akhan S, Köse Ş, Erdinç FŞ, Akalın EH, Tabak ÖF, Pullukçu H, Batum Ö, Şimşek Yavuz S, Turhan Ö, Yıldırmak MT, Köksal İ, Taşova Y, Korten V, Yılmaz G, Çelen MK, Altın S, Çelik İ, Bayındır Y, Karaoğlan İ, Yılmaz A, Özkul A, Gür H, Unal S; CoronaVac Study Group. Tanriover MD, et al. Lancet. 2021 Jul 17;398(10296):213-222. doi: 10.1016/S0140-6736(21)01429-X. Epub 2021 Jul 8. Lancet. 2021. PMID: 34246358 Free PMC article. Clinical Trial.
Characteristics and outcomes of carbapenemase harbouring carbapenem-resistant Klebsiella spp. bloodstream infections: a multicentre prospective cohort study in an OXA-48 endemic setting.
Isler B, Özer B, Çınar G, Aslan AT, Vatansever C, Falconer C, Dolapçı İ, Şimşek F, Tülek N, Demirkaya H, Menekşe Ş, Akalin H, Balkan İİ, Aydın M, Tigen ET, Demir SK, Kapmaz M, Keske Ş, Doğan Ö, Arabacı Ç, Yağcı S, Hazırolan G, Bakır VO, Gönen M, Chatfield MD, Forde B, Saltoğlu N, Azap A, Azap Ö, Akova M, Paterson DL, Can F, Ergönül Ö. Isler B, et al. Among authors: aydin m. Eur J Clin Microbiol Infect Dis. 2022 May;41(5):841-847. doi: 10.1007/s10096-022-04425-4. Epub 2022 Mar 17. Eur J Clin Microbiol Infect Dis. 2022. PMID: 35301623
Comparison of ceftazidime-avibactam susceptibility testing methods against OXA-48-like carrying Klebsiella blood stream isolates.
Isler B, Vatansever C, Özer B, Çınar G, Aslan AT, Stewart A, Simos P, Falconer C, Bauer MJ, Forde B, Harris P, Şimşek F, Tülek N, Demirkaya H, Menekşe Ş, Akalin H, Balkan İİ, Aydın M, Tigen ET, Demir SK, Kapmaz M, Keske Ş, Doğan Ö, Arabacı Ç, Yağcı S, Hazırolan G, Bakır VO, Gönen M, Saltoğlu N, Azap A, Azap Ö, Akova M, Ergönül Ö, Paterson DL, Can F. Isler B, et al. Among authors: aydin m. Diagn Microbiol Infect Dis. 2022 Sep;104(1):115745. doi: 10.1016/j.diagmicrobio.2022.115745. Epub 2022 Jun 18. Diagn Microbiol Infect Dis. 2022. PMID: 35843111
1,649 results